Sodium Cantharidinate/Vitamin B6

斑蝥酸钠/维生素B6

Report date: 2025/07/16 14:28:48

Base Information

Drug NameSodium Cantharidinate/Vitamin B6
Drug Alias Name斑蝥酸钠维生素B6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsLiver Neoplasms
Global Approved IndicationsLung NeoplasmsLiver Neoplasms
Approved Indications in ChinaLung NeoplasmsLiver Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsYes Sodium CantharidinateVitamin B6
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuizhou Baiqiang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuizhou Baiqiang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A